logo
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit

NEW YORK, May 6, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Viatris Inc. ('Viatris' or the 'Company') (NASDAQ: VTRS) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146934&wire=4
VTRS investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the complaint, defendants provided investors with material information concerning the failed inspection of Viatris' Indore, India facility. Defendants' statements misrepresented the FDA's issuance of a warning letter and its impact on Viatris' operations. Defendants routinely referred to the impact of the warning letter as a mere 'minor headwind' for the Company. On February 27, 2025, Viatris announced its financial results for the fourth quarter and full fiscal year 2024 and provided disappointing fiscal 2025 guidance. The Company attributed below-expectation guidance on 'the expected financial impact from Indore facility warning letter and import alert.' Following this news, the price of Viatris' common stock declined dramatically. From a closing market price of $11.24 per share on February 26, 2025, Viatris' stock price fell to $9.53 per share on February 27, 2025, a decline of about 15.21% in the span of just a single day.
WHAT'S NEXT? If you suffered a loss in Viatris during the relevant time frame, you have until June 3, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/levi–korsinsky-reminds-shareholders-of-a-lead-plaintiff-deadline-of-june-3-2025-in-viatris-inc-lawsuit–vtrs-302446534.html
SOURCE Levi & Korsinsky, LLP

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TNL Mediagene and WOWOW Expand Promotional Channels with New Model Linking Viewership to Purchases
TNL Mediagene and WOWOW Expand Promotional Channels with New Model Linking Viewership to Purchases

Malaysian Reserve

time12 hours ago

  • Malaysian Reserve

TNL Mediagene and WOWOW Expand Promotional Channels with New Model Linking Viewership to Purchases

NEW YORK and TOKYO, June 11, 2025 /PRNewswire/ — Mediagene Inc.(the 'Company'), a subsidiary of TNL Mediagene (Nasdaq: TNMG), today announced the launch of 'CoSTORY with WOWOW,' a promotional menu created in collaboration with Japan's premium pay TV broadcaster WOWOW INC ('WOWOW'), on its social commerce platform 'CoSTORY,' as part of a new initiative realized through a business alliance between the two companies. Background of the Service Launch TNL Mediagene group, including the Company, entered into a business alliance agreement with WOWOW on October 18, 2024, to foster growth in their respective media businesses and jointly develop unique, forward-thinking media ventures. As part of our collaboration with WOWOW, we will add this promotional menu to our social commerce platform 'CoSTORY'. We aim to create a new form of content distribution that leverages diverse approaches such as media mix to convey the stories and appeal of products in a multi-layered manner. About the New Promotional Menu 'CoSTORY with WOWOW' The newly added promotional menu, 'CoSTORY with WOWOW', is a unique initiative that combines the strengths of both companies: The Company's expertise in content commerce and its operation of the social commerce platform 'CoSTORY,' and WOWOW's significant viewer touchpoints through its broadcasting and transmitted services. Promotional campaigns under the promotional menu can be developed to connect viewing experiences directly to purchase opportunities. This is achieved by utilizing The Company's various media outlets and SNS channels, which reach approximately 30 million monthly readers, in addition to WOWOW's extensive network, which includes broadcasting, transmitted, on-demand services, and online pages for its roughly 2.3 million subscriptions. We will formulate and implement plans for each product based on its characteristics and target segment in order to achieve the most effective promotion. Introduction to CoSTORY CoSTORY is a social commerce platform of the Company where users can pre-order and purchase unique products, exclusive items, and goods not yet widely available on the general market. Website: Instagram: X (formerly Twitter): Future Development With the start of this promotional menu, the Company and WOWOW will further strengthen their collaboration. They both aim to drive growth and development in their media businesses through future projects, including the joint operation of new social media channels and the planning of integrated solutions that combine TV commercials with digital advertising. About Mediagene Inc. Mediagene Inc. operates a total of 17 brands, including 14 media tailored for specific target communities and 3 commerce services. Its portfolio features Business Insider Japan, offering economic news for millennials; Gizmodo Japan, which covers tech and new products; Mashing Up, a community-driven media focused on fostering an inclusive future; and Machi-ya, a crowdfunding service specializing in gadgets. About TNL Mediagene Headquartered in Tokyo, TNL Mediagene was formed in May 2023 through the merger of Taiwan's The News Lens Co., Ltd. and Japan's Mediagene Inc., two of the region's leading independent digital media groups. The company's operations span original and licensed media brands in Japanese, Chinese, and English, covering topics such as news, business, technology, science, food, sports, and lifestyle. It also offers AI-driven advertising services, marketing technology platforms, e-commerce, and innovative solutions tailored to the needs of advertising agencies. Known for its political neutrality, appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 500 employees across Asia, with offices in Japan, Taiwan, and Hong Kong. Disclaimer This document is a translation of the Japanese press release issued by Mediagene Inc. for reference purposes only. In the event of any discrepancies between this translated document and the original Japanese version, the original Japanese version shall prevail. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene's future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'intend,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'ongoing,' 'target,' 'seek' or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene's filings with the Securities and Exchange Commission. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Malaysian Reserve

time2 days ago

  • Malaysian Reserve

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 10, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) '[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Malaysian Reserve

time2 days ago

  • Malaysian Reserve

Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, June 9, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz continues its investigation of EchoStar Corporation ('EchoStar' or the 'Company') (NASDAQ: SATS) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ECHOSTAR CORPORATION (SATS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 12, 2025, The Wall Street Journal reported that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network. On this news, EchoStar's stock price fell $4.01, or 16.6%, to close at $20.18 per share on May 12, 2025, thereby injuring investors. Then, on May 30, 2025, EchoStar disclosed that it had 'elected not to make an approximately $326 million cash interest payment' in order to 'allow time for the FCC to provide the relief requested in [the Company's] Response' to the FCC's compliance investigation. On this news, EchoStar's stock price fell $2.44, or 12.1%, to close at $17.73 per share on May 30, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you purchased EchoStar securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact Us:The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz310-914-5007fcruz@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store